WELL Health
Trending >

Maxar Technologies stock is too risky right now, says this portfolio manager

Canopy Growth Corp

Rick Stuchberry
Unless you’re wanting to trade it, stay away from Maxar Technologies (Maxar Technologies Stock Quote, Chart TSX, NYSE:MAXR) until the stock shows some stability. That’s the advice from Rick Stuchberry of Wellington-Altus Private Wealth, who says his firm has sold its position in MAXR.

Formerly known as MacDonald, Dettwiler and Associates, Maxar Technologies saw its share price drop further in trading on Monday as the company continues to reel from a couple of body blows over recent weeks involving a stability failure in its WorldView-4 satellite and the abrupt stepping down of CEO Howard Lance. Those events come after a 2018 in which Maxar fought a short-seller attack, wrote down its satellite business and suffered a dramatic plunge in its share price.

All of which is to say that the stock remains particularly volatile right now, says Stuchberry, portfolio manager at Wellington-Altus.

“We owned this about a year ago and got more or less stopped out that the news wasn’t good and the stock wasn’t going in the proper direction, so we basically surrendered and sold the stock,” says Stuchberry, in conversation with BNN Bloomberg Monday.

“I think on this one, unless you’re going to trade it, let the thing form a base for you and go sideways for a while and show that the problems that it has faced in the past few months are behind you,” he says.

MAXR was drifting lower over the first half of 2018 before an earnings miss in late July sparked a selloff that basically continues to this day. To date, the stock has lost 92 per cent of its value since the start of 2018.

“They have to iron these problems out and once that’s done then maybe they can recover again,” says Stuchberry. “The stocks in this sector do have a volatility background to them.”

Launched two years ago, Maxar says that its image-generating satellite’s failure will knock $85 million in annual revenue off of its books, with the company intending to seek a full recovery for the losses through insurance claims.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

About The Author /

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.
insta twitter facebook


Leave a Reply